key: cord-0992289-ee7ojrrf authors: Chen, Dunjin; Yang, Huixia; Cao, Yun; Cheng, Weiwei; Duan, Tao; Fan, Cuifang; Fan, Shangrong; Feng, Ling; Gao, Yuanmei; He, Fang; He, Jing; Hu, Yali; Jiang, Yi; Li, Yimin; Li, Jiafu; Li, Xiaotian; Li, Xuelan; Lin, Kangguang; Liu, Caixia; Liu, Juntao; Liu, Xinghui; Pan, Xingfei; Pang, Qiumei; Pu, Meihua; Qi, Hongbo; Shi, Chunyan; Sun, Yu; Sun, Jingxia; Wang, Xietong; Wang, Yichun; Wang, Zilian; Wang, Zhijian; Wang, Chen; Wu, Suqiu; Xin, Hong; Yan, Jianying; Zhao, Yangyu; Zheng, Jun; Zhou, Yihua; Zou, Li; Zeng, Yingchun; Zhang, Yuanzhen; Guan, Xiaoming title: Expert consensus for managing pregnant women and neonates born to mothers with suspected or confirmed novel coronavirus (COVID‐19) infection date: 2020-04-01 journal: Int J Gynaecol Obstet DOI: 10.1002/ijgo.13146 sha: 269bd5082e834b5aaf63feca84cc15e81932e113 doc_id: 992289 cord_uid: ee7ojrrf OBJECTIVE: To provide clinical management guidelines for novel coronavirus (COVID‐19) in pregnancy. METHODS: On February 5, 2020, a multidisciplinary teleconference comprising Chinese physicians and researchers was held and medical management strategies of COVID‐19 infection in pregnancy were discussed. RESULTS: Ten key recommendations were provided for the management of COVID‐19 infections in pregnancy. CONCLUSION: Currently, there is no clear evidence regarding optimal delivery timing, the safety of vaginal delivery, or whether cesarean delivery prevents vertical transmission at the time of delivery; therefore, route of delivery and delivery timing should be individualized based on obstetrical indications and maternal–fetal status. Other coronaviruses, such as severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) have caused more than 10 000 infected patients worldwide. The mortality rate of MERS-CoV infection approaches 37%. [2] [3] [4] [5] The mortality rate of SARS-CoV infection is 10% in the general population and as high as 25% in pregnant women. 6 China has adopted infection control measures to isolate exposed people and suspected cases in accordance with international standards. Chinese health officials continue to regularly update diagnosis and treatment protocols and educate and update the public and front-line healthcare providers. 7 China developed the 5th edition of the National Health and Medical Commission Diagnostic Standard with suspected or probable COVID-19 infection in response to this recent epidemic. 8 On February 5, 2020, a multidisciplinary teleconference comprising maternal-fetal medicine and other experts in or from China and the USA was held to discuss recommendations specific to the management of pregnant patients. From this meeting come the recommendations discussed below (Fig. 1) . These recommendations are likely to evolve as the course of this novel disease unfolds. Women with symptoms suggestive of COVID-19 should be immediately isolated in a single room for screening, and movement of the patient throughout the facility should be limited. Confirmed cases should be treated in a negative pressure room or isolation ward. Women with signs of critical illness should be immediately transferred to an intensive or critical care unit with negative pressure or equivalent. 8 Hospitals should establish a dedicated negative pressure operating room for pregnant women who must deliver with confirmed COVID-19 infection, and a dedicated neonatal negative pressure isolation room for newborns should be established. Ideally, these rooms will be close to one another, to limit traffic and movement of persons under investigation (PUI) or women and infants with known infection. Visitation may also need to be limited, as close familial contacts may still be within the window in which they are infectious but asymptomatic. It is critical to distinguish COVID-19 from the following infectious and non-infectious diseases, and to continue to pay close attention to and appropriately treat patients with other infections (Table 1) . There is currently no clear evidence of definitive treatment for COVID-19, and the mainstay of treatment is supportive care. Even while screening, provide supportive care: ensure adequate rest and sleep; ensure enough caloric intake; provide supplemental oxygen or respiratory support as needed; and maintain fluid and electrolyte balance. Initiate broad-spectrum antimicrobial therapy to cover communityacquired pneumonia while initiating the diagnostic work-up. In an effort to reduce a rising number of deaths due to severe COVID-19 disease, Chinese health officials have begun to recommend starting antiretroviral agents even though there is little empirical data supporting their efficacy. These may include: (a) Alpha-interferon inhalation (5 million U each time for adults, add 2 mL of sterile water for injection, twice per day). The use of this drug in early pregnancy has the risk of hindering fetal growth and development and fully informed oral consent should be obtained. 9 (b) Lopinavir/ritonavir (200 mg/50 mg, per capsule) two capsules, twice per day. Lopinavir/ritonavir has been used in the treatment of pregnancy with HIV and the data show no significant teratogenicity 10 ; the concentration in breast milk is very low, and no lopinavir/ritonavir is detected in breastfed infants. [11] [12] [13] [14] The use of antiretroviral medications has not been recommended worldwide, and providers should consider the most up-to-date F I G U R E 1 Flowchart of consultation process for pregnant women with suspected COVID-19 infection. Chest imaging is critical for the complete evaluation of COVID-19 infection and should not be withheld in pregnant women. Both X-ray and computed tomography (CT) use radiation. Impact on the fetus is related to the gestational age at the time of the examination and the dose of radiation exposure. 8 Routine diagnostic imaging doses are much lower than 1 Gy, the threshold for early embryonic injury. 15, 16 There have been no reports of fetal malformations, restricted growth, or miscarriage at exposures below 50 mGy. 17 The minimum radiation dose associated with developmental delay is above 610 mGy. [18] [19] [20] [21] According to data cited in clinical guidelines from the American Gynecology, 23 when pregnant women undergo a single chest X-ray examination, the fetus will receive a radiation dose of 0.0005-0.01 mGy. CT is associated with a fetal radiation dose of 0.01-0.66 mGy. 16 During the CT examination, intravenous iodine contrast agent can enter the fetal circulation and amniotic fluid through the placenta, but animal studies have shown that it has no teratogenic or mutagenic effects. [24] [25] [26] Due to a favorable risk-benefit ratio, X-ray and CT should be used for pregnant women as clinically necessary, with informed consent obtained. Abdominal shielding and limiting exposure times to the minimum necessary may reduce the total fetal radiation dose. While the actual clinical course in pregnancy with COVID-19 is still being elucidated, it is recommended that symptomatic pregnant women be admitted and isolated in an intensive care or critical care unit with negative pressure rooms. Pregnant women may have better uteroplacental oxygenation while lying in a lateral-decubitus position, regardless of the mother's respiratory status. Electronic fetal heart rate monitoring and/or ultrasound should be used to evaluate the fetal status dependent upon the gestational age. Doppler assessment for the presence of fetal heart tones will suffice in the previable period. More advanced monitoring is recommended once the fetus reaches viability. Routine diagnostic procedures such as amniocentesis are not recommended in mothers with active infection. Should amniocentesis be considered as part of a diagnostic work-up (such as evaluation for intra-amniotic inflammation and infection), the risks and benefits of such procedures should be discussed with the patient and appropriate informed consent obtained. termination, and decisions regarding delivery timing must be T A B L E 1 Differential diagnosis of acute severe respiratory distress. Pregnant women who have a suspected or confirmed COVID-19 infection should be encouraged to report symptoms immediately. They should be screened promptly by qualified medical personnel and directed to present to the appropriate hospital if clinically required. Hospitals with isolation rooms or negative pressure wards should preferentially admit these patients into those units rather than have the patient triaged and transferred between multiple clinics and facilities High Critical For pregnant women with confirmed COVID-19 infection, routine antenatal examination delivery should be carried out in a negative pressure isolation ward whenever possible, and the medical staff who take care of these women should wear protective clothing, N95 masks, goggles, and gloves before contact with the patients Low Critical The timing of childbirth should be individualized. Timing should be based on maternal and fetal wellbeing, gestational age, and other concomitant conditions, not solely because the pregnant patient is infected. The mode of delivery should be based on routine obstetrical indications, allowing vaginal delivery when possible and reserving cesarean delivery for when obstetrically necessary Low Important In pregnant women with COVID-19 infection who need a cesarean delivery, it is reasonable to consider regional analgesia. If the maternal respiratory condition appears to be rapidly deteriorating, general endotracheal anesthesia may be safer; multidisciplinary planning with the anesthesiology team is recommended It is recommended that obstetricians, neonatologists, anesthesiologists, critical care medical specialists, and other medical professionals jointly manage pregnant women with COVID-19 pneumonia and strictly prevent cross-infection. Medical staff caring for these patients must monitor themselves daily for clinical manifestations such as fever and cough. If COVID-19 infection pneumonia occurs, medical staff should also be treated in isolation wards Low Important All staff engaged in obstetrics should receive training for COVID-19 infection control High Critical Note: The quality and importance of evidence reported in this paper has been adapted from the quality and importance of evidence criteria described in the Canadian Task Force on Preventive Health Care (https://canad ianta skfor ce.ca/wp-conte nt/uploa ds/2016/12/proce dural-manual-en_2014_Archi ved.pdf). Pregnant women are uniquely susceptible to severe disease in the setting of viral infections. At present, there are no effective drugs or preventive vaccines available targeting COVID-19. Personal protection and patient isolation are key to controlling further infection and viral spread. 43, 44 We recommend the following advice to all patients who live in endemic areas: 1. Always maintain good personal hygiene habits. Wash hands with soap and water; medical staff should wear masks. Non-infected patients should follow local guidance on mask-wearing. Avoid close contact with others, reduce participation in large-scale public events, dinners, and other places with large crowds. Be proactive: stay abreast of the latest recommendations regarding COVID-19 infection. Those with suspected symptoms should seek medical treatment and follow all recommendations regarding treatment and contact isolation in accordance with their doctor's advice. Recommendations for managing pregnant women and neonates born to mothers with suspected or confirmed COVID-19 infection are summarized in Table 2 . We would like to thank Catherine Eppes, Karin Fox, and Michael Belfort for essential revision of this manuscript. DC and HY initiated the study; DC wrote the draft based on expert advice for all authors in this manuscript. The authors have no conflicts of interest. A novel coronavirus associated with severe acute respiratory syndrome Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia World Health Organization. Summary of probable SARS cases with onset of illness from 1 Middle East respiratory syndrome coronavirus (MERS-CoV) [WHO website Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study Diagnosis and treatment guideline for COVID-19 infection(trial version 6) [in Chinese]. National Health Commission of the People's Republic of China website Neonatal thyroid function after administration of IV iodinated contrast agent to 21 pregnant patients Antiviral inflammation during early pregnancy reduces placental and fetal growth trajectories Safety and efficacy of lopinavir/ritonavir during pregnancy: A systematic review Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks postpartum: Results of the BAN Study Is infant exposure to antiretroviral drugs during breastfeeding quantitatively important? A systematic review and meta-analysis of pharmacokinetic studies Treatment of viral infections during pregnancy Committee Opinion No. 723: Guidelines for diagnostic imaging during pregnancy and lactation ACR-SPR practice parameter for imaging pregnant or potentially pregnant adolescents and women with ionizing radiation Quality initiatives: Guidelines for use of medical imaging during pregnancy and lactation CT, and ultrasound in the evaluation of obstetric and gynecologic patients Imaging the pregnant patient for nonobstetric conditions: Algorithms and radiation dose considerations Gadopentetate: Drugs and lactation database (LactMed) Mental retardation following in utero exposure to the atomic bombs of Hiroshima and Nagasaki ACR-SPR practice parameter for imaging pregnant or potentially pregnant adolescents and women with ionizing radiation Guidelines for diagnostic imaging during pregnancy and lactation. Committee Opinion No. 723. American College of Obstetricians and Gynecologists Discussion: Severe mental retardation and cancer among atomic bomb survivors exposed in utero ACR guidance document on MR safe practices: 2013 The use of iodinated and gadolinium contrast media during pregnancy and lactation The effect of venovenous ECMO on the pharmacokinetics of Ritonavir, Darunavir, Tenofovir and Lamivudine Surviving sepsis campaign: International Guidelines for Management of Sepsis and Septic Shock SMFM Consult Series # 47: Sepsis during pregnancy and the puerperium Current challenges in the management of sepsis in ICUs in resource-poor settings and suggestions for the future Circulating high sensitivity troponin T in severe sepsis and septic shock: Distribution, associated factors, and relation to outcome Acute respiratory failure and mechanical ventilation in pregnant patient: A narrative review of literature Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected [WHO website Effect of high-flow nasal cannula oxygen therapy in adults with acute hypoxemic respiratory failure: A meta-analysis of randomized controlled trials High flow nasal cannulae oxygen therapy in acute-moderate hypercapnic respiratory failure Official ERS/ATS clinical practice guidelines: Noninvasive ventilation for acute respiratory failure Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus Delivery during extracorporeal membrane oxygenation (ECMO) support of pregnant woman with severe respiratory distress syndrome caused by influenza: A case report and review of the literature 225-Management guidelines for obstetric patients and neonates born to mothers with suspected or probable severe acute respiratory syndrome (SARS) Pneumonia during pregnancy: Has modern technology improved maternal and fetal outcome? Severe acute respiratory syndrome and pregnancy Infectious Diseases, 9th edn People's Medical Publishing House National Health Commission of the People's Republic of China